ストックスクリーナーアプリを入手
25.00
0.64%
0.16
プレマーケット:
25.42
0.42
+1.68%
前日終値:
$24.84
開ける：
$24.85
24時間の取引高:
13.31M
Relative Volume:
1.36
時価総額：
$9.73B
収益：
$3.14B
当期純損益:
$-3.36B
株価収益率:
-2.8637
EPS:
-8.73
ネットキャッシュフロー:
$-4.03B
1週間 パフォーマンス:
+2.84%
1か月 パフォーマンス:
-10.78%
6か月 パフォーマンス:
-27.97%
1年 パフォーマンス:
-65.27%
1日の値動き範囲:
$23.91
$25.78
1週間の範囲:
$23.18
$25.90
52週間の値動き範囲:
$23.15
$73.35
Moderna Inc Stock (MRNA) Company Profile
MRNA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MRNA
Moderna Inc
|
25.00 | 9.66B | 3.14B | -3.36B | -4.03B | -8.73 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.15 | 100.34B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
585.50 | 60.95B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.73 | 60.46B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
734.35 | 46.04B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
332.20 | 36.02B | 3.81B | -644.79M | -669.77M | -6.24 |
Moderna Inc Stock (MRNA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-13 | 開始されました | Citigroup | Neutral |
| 2025-02-18 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2025-01-29 | ダウングレード | Goldman | Buy → Neutral |
| 2024-12-18 | ダウングレード | Argus | Buy → Hold |
| 2024-12-10 | 再開されました | BofA Securities | Underperform |
| 2024-11-19 | 開始されました | Berenberg | Hold |
| 2024-11-18 | アップグレード | HSBC Securities | Hold → Buy |
| 2024-11-15 | 開始されました | Wolfe Research | Underperform |
| 2024-10-17 | 開始されました | Bernstein | Mkt Perform |
| 2024-09-13 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2024-09-13 | ダウングレード | Jefferies | Buy → Hold |
| 2024-09-13 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2024-08-28 | アップグレード | HSBC Securities | Reduce → Hold |
| 2024-08-07 | アップグレード | Deutsche Bank | Sell → Hold |
| 2024-08-05 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-02-26 | ダウングレード | HSBC Securities | Hold → Reduce |
| 2024-01-02 | アップグレード | Oppenheimer | Perform → Outperform |
| 2023-11-29 | 開始されました | Canaccord Genuity | Hold |
| 2023-11-03 | アップグレード | HSBC Securities | Reduce → Hold |
| 2023-11-02 | ダウングレード | Deutsche Bank | Hold → Sell |
| 2023-08-04 | ダウングレード | TD Cowen | Outperform → Market Perform |
| 2023-08-03 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2023-07-24 | 開始されました | William Blair | Mkt Perform |
| 2023-07-14 | 開始されました | HSBC Securities | Reduce |
| 2023-06-26 | アップグレード | UBS | Neutral → Buy |
| 2023-04-26 | 開始されました | Guggenheim | Neutral |
| 2023-03-13 | アップグレード | TD Cowen | Market Perform → Outperform |
| 2023-03-02 | 開始されました | RBC Capital Mkts | Outperform |
| 2023-02-24 | ダウングレード | SVB Securities | Market Perform → Underperform |
| 2022-12-19 | アップグレード | Jefferies | Hold → Buy |
| 2022-12-14 | ダウングレード | Chardan Capital Markets | Buy → Neutral |
| 2022-10-21 | アップグレード | SVB Leerink | Underperform → Mkt Perform |
| 2022-09-08 | アップグレード | Deutsche Bank | Hold → Buy |
| 2022-02-01 | アップグレード | Redburn | Sell → Neutral |
| 2022-01-26 | アップグレード | Deutsche Bank | Sell → Hold |
| 2022-01-21 | アップグレード | BofA Securities | Underperform → Neutral |
| 2022-01-21 | 開始されました | UBS | Neutral |
| 2021-12-07 | 開始されました | Cowen | Market Perform |
| 2021-11-09 | 開始されました | Wolfe Research | Outperform |
| 2021-10-22 | 開始されました | Deutsche Bank | Sell |
| 2021-10-15 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2021-08-06 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2021-08-06 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2021-07-15 | 繰り返されました | Jefferies | Hold |
| 2021-02-01 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2020-12-16 | ダウングレード | Jefferies | Buy → Hold |
| 2020-12-16 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-09 | ダウングレード | Needham | Buy → Hold |
| 2020-11-23 | 開始されました | Wells Fargo | Equal Weight |
| 2020-11-17 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
| 2020-09-08 | ダウングレード | SVB Leerink | Mkt Perform → Underperform |
| 2020-07-23 | 開始されました | SVB Leerink | Mkt Perform |
| 2020-07-20 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2020-07-13 | 開始されました | Jefferies | Buy |
| 2020-06-30 | 開始されました | Argus | Buy |
| 2020-06-08 | 開始されました | Barclays | Overweight |
| 2020-04-30 | 開始されました | BMO Capital Markets | Outperform |
| 2020-03-05 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2019-12-03 | 再開されました | BofA/Merrill | Buy |
| 2019-10-25 | 開始されました | ROTH Capital | Buy |
| 2019-04-05 | 開始されました | Chardan Capital Markets | Buy |
すべてを表示
Moderna Inc (MRNA) 最新ニュース
Woodline Partners LP Has $6.93 Million Stock Position in Moderna, Inc. $MRNA - MarketBeat
Moderna (NASDAQ:MRNA) Shares Down 5.6%Here's What Happened - MarketBeat
Douglas Lane & Associates LLC Acquires 56,648 Shares of Moderna, Inc. $MRNA - MarketBeat
Moderna, Inc. $MRNA Shares Acquired by UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC - MarketBeat
Acadian Asset Management LLC Grows Stock Holdings in Moderna, Inc. $MRNA - MarketBeat
Moderna, Inc. (NASDAQ:MRNA) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Moderna Reports 8-Fold Jump In Antibodies With Updated Spikevax - AOL.com
Moderna (NASDAQ:MRNA) Trading 6.6% HigherHere's What Happened - MarketBeat
West Coast states issue own vaccine guidance citing “politicization of science” under Trump - Seeking Alpha
Quarterly Earnings: Is now the right time to enter Moderna IncTake Profit & Expert Curated Trade Setups - خودرو بانک
History Review: Is Moderna Inc stock a value trapMarket Weekly Review & Accurate Buy Signal Notifications - خودرو بانک
Moderna, Inc. Securities Lawsuit Investigation - Claim Depot
U.S. health insurers pledge continuing coverage of COVID shots ahead of ACIP meeting - Seeking Alpha
Moderna Shares Surge After Recording Positive Phase 4 Prelim Data on COVID-19 Drug - inkl
What's Going On With Moderna Stock Wednesday? - Benzinga
MRNA Stock Rises as Updated COVID-19 Jab Shows Strong Immune Response - TradingView
Strs Ohio Makes New $2.05 Million Investment in Moderna, Inc. $MRNA - MarketBeat
Moderna, Inc. $MRNA Position Reduced by Swedbank AB - MarketBeat
Insider Buy: Can NextNav Inc. stock double in the next yearWeekly Investment Summary & AI Enhanced Trade Execution Alerts - خودرو بانک
NIO, RIVN, MRNA, META, BMNR: 5 Trending Stocks TodayBitMine Immersion Techs (AMEX:BMNR) - Benzinga
Sentiment Review: How does Moderna Inc correlate with Nasdaq2025 Market Overview & Smart Swing Trading Alerts - خودرو بانک
Moderna (MRNA) Extends Gains Amid Vaccine Concerns - GuruFocus
Moderna is up on the release of positive results for reformulated Covid vaccine - Sherwood News
Gains Report: What are the future prospects of Moderna IncEarnings Trend Report & Reliable Price Breakout Signals - خودرو بانک
Why Moderna (MRNA) Stock Is Trading Up Today - FinancialContent
Moderna Reports 8-Fold Jump In Antibodies With Updated Spikevax - Benzinga
Dip Buying: Is Moderna Inc backed by strong institutional buyingJuly 2025 Pullbacks & Low Risk Entry Point Tips - خودرو بانک
Moderna president talks revenue and focus on new vaccine development, including cancer - Fox Business
Pfizer, Moderna post data supporting COVID shots after Trump demand - Seeking Alpha
Moderna (MRNA) Reports Promising Spikevax Data Against COVID-19 Variant - GuruFocus
How Renewed Scrutiny of Pediatric Vaccine Safety at Moderna (MRNA) Has Changed Its Investment Story - Yahoo Finance
Moderna Says Phase 4 Trial Demonstrates Positive Preliminary Immunogenicity Data for 2025-2026 Spikevax Formula - MarketScreener
Moderna Announces Updated COVID-19 Vaccine Against LP.8.1 Variant Generates Strong Immune Response in Humans - Rock Hill Herald
Moderna COVID-19 vaccine shows 8-fold antibody increase against LP.8.1 variant - StreetInsider
8x Stronger Immune Response: Moderna's New COVID Vaccine Tackles Dominant LP.8.1 Variant in Trial - Stock Titan
China’s Therapeutic mRNA Vaccine Pipeline For Oncology The Largest Globally - insights.citeline.com
Jobs Data: Is Moderna Inc. stock a value trap2025 Trading Recap & Fast Entry High Yield Tips - خودرو بانک
Market Trends: Can Moderna Inc. deliver alphaJuly 2025 Final Week & AI Driven Stock Reports - خودرو بانک
Moderna Inc (MRNA) 財務データ
収益
当期純利益
現金流量
EPS
0.62%
0.57%
大文字化:
|
ボリューム (24 時間):